Want to join the conversation?
$VNO 2Q15 Call: Our 2Q15 comparable FFO was $2.30 per share, 5.7% higher than 2Q14. Excluding income in 2Q14 from asset sales of our real estate fund, asset sales really should not be included in FFO at all. But excluding those fund asset sales, comparable FFO per share would have increased a whopping 20%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?